Halfway Home Pets

Lets' get them the life they need

In a recent press release, Foresite Capital Management announced the appointment of Dr. Molly He, the former director of Illumina, as the firm’s venture partner. Dr. He has over one decade of experience in genomic research and pharmacology.

Dr. He becomes a member of Foresite Capital

According to Foresite Capital Management’s managing director, Mr. Jim Tananbaum, Dr. He is a prominent scientist with a keen interest in the next-generation sequencing. He also added that Foresite Capital Management is glad to have Dr. He as its venture partner. Based on her work background in drug development and genomics, she is bound to be a great asset to this company. Before joining Foresite Capital Management, Dr. He worked at Illumina where she oversaw protein reagent innovation and their subsequent improvements. She also used to work for Pacific Biosciences as she spent her time researching on molecular real-time sequencing chemistry. Dr. He is a graduate of Nankai University and holds a doctorate from the University of California. She has published various articles, and she is a proud owner of over 20 patents in protein biophysics and what Jim knows.

About Mr. Jim Tananbaum

Mr. Jim Tananbaum is a business executive and the founder of Foresite Capital Management, a San Francisco-based company. Mr. Tananbaum is a scholar, and he has studied in some of the finest colleges, such as Yale University, MIT, and Harvard University. Mr. Tananbaum holds a doctorate in medicine, which he acquired in 1989 from the revered Harvard Medical School. He also volunteers at Yale University as a member and president of the Advisory Board. Mr. Tananbaum also serves as the chief advisor for the Harvard-MIT HST Program and more information click here.

Mr. Tananbaum has worked for many firms, including GelTex, a business that manufactures non-systemic drugs. He is the founder of GelTex and managed this company for five years before joining Sierra Ventures in 1993. Mr. Tananbaum later helped establish Theravance (THRX) and served as its chief executive. He has served as the M.D. of Prospect Venture Partners for close to a decade. While working for this firm, he oversaw the PVP2 & PVP3 project. Currently, he serves as the principal of Foresite Capital Management, a company that manages healthcare investment fund and resume him.

With the advancement in technology, new trends come in almost every other day. Some people love to keep an eye on the new technological trends and are making money out of it. But, for them, it is not just about the money. It is about how technology is changing the world we live in.

Jason Hope recently blogged about his thoughts about Internet of Things. He described how people could benefit from IoT and to encourage people to embrace it.

While most people think of smartphones when they think of IoT, it is much more than that. Everything we see around us, from car to our homes, technology is used to control all of it. Internet of Things has made a lot of stuff possible. The cameras that are installed in our homes send data via technology to our smartphones so that we can keep our loved ones safe. It is just one example of how IoT have made our life easier and more secure.

Follow @jasonhope

Jason Hope Actively supports young entrepreneurs and offer investments on their technological products. While he was growing up, he realized that only a few people would support such projects and wanted to change it. Jason Hope has an incubation program from where he picks up talented and young entrepreneurs who have great ideas and invests on their plans and implementation. Jason Hope supports a number of non-profit organizations and believes in giving back to the community. He works closely with many foundations that help those in need.

Read more about Jason Hope on Crunchbase.